Short answer
ASPEN AEROGELS INC (ASPN) filed its Q2 2026 10-Q quarterly report on Aug 7, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $50M (down 36.1% year over year) with net income of −$23M.
Q2 2026 key financials · XBRL
- Revenue
- $50M
- −36.1% YoY · +31.6% QoQ
- Net income
- −$23M
- −156.9% YoY · +1.8% QoQ
- Operating margin
- -57.7%
- Gross margin
- 6.5%
- EPS (diluted)
- −$0.28
- −154.5% YoY · +3.4% QoQ
Source: XBRL data from the ASPEN AEROGELS INC (ASPN) Q2 2026 10-Q on SEC EDGAR. USD.
ASPEN AEROGELS INC Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Risk Factors section not provided; submitted text covers Items 2–6 only
- No new, updated, regulatory, operational, competitive, market, or financial risks disclosed
- No equity repurchases during quarter ended June 30, 2026
- No defaults upon senior securities reported
- No Rule 10b5-1 or non-Rule 10b5-1 trading arrangements adopted, modified, or terminated
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ASPEN AEROGELS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.